Hyperfine, Inc. (HYPR) - Dilution Analysis

10-Q filing | 84.2M shares outstanding

S-3 filing: Hyperfine, Inc. is registering the resale of up to 1,083,335 shares of Class A common stock issuable upon the exercise of outstanding warrants.

10-K filing | 81.8M shares outstanding

10-Q filing | 79.0M shares outstanding

10-Q filing | 62.8M shares outstanding

10-K filing | 62.8M shares outstanding

10-Q filing | 57.9M shares outstanding

10-Q filing | 57.6M shares outstanding

10-Q filing | 57.0M shares outstanding

10-K filing | 56.9M shares outstanding

S-3 filing: Hyperfine, Inc. files an S-3 form to offer up to $150,000,000 of any combination of Class A common stock, preferred stock, and debt securities, and also offers Class A common stock having an aggregate offering price of up to $50,000,000 in an "at the market offering" through B. Riley.

10-Q filing | 56.5M shares outstanding

10-Q filing | 56.3M shares outstanding

8-K filing: Hyperfine, Inc. amended its bylaws to replace the Executive Chairman with a Chairperson, approved changes to the Nonemployee Director Compensation Policy, and granted special one-time equity grants to certain directors, including options to purchase 85,000 shares each to John Dahldorf, Ruth Fattori, and Daniel J. Wolterman, and 237,437 shares to R. Scott Huennekens, contingent on cancellation of a previous grant.

10-Q filing | 56.0M shares outstanding

10-K filing | 56.0M shares outstanding

POS AM filing: This is a POS AM filing for the resale of Class A and Class B common stock by selling securityholders.

10-Q filing | 55.5M shares outstanding

10-Q filing | 55.4M shares outstanding

10-Q filing | 55.3M shares outstanding

POS AM filing: This prospectus relates to the resale from time to time by the Selling Securityholders named in this prospectus of up to (i) 5,025,000 shares of Class A common stock, (ii) 12,122,000 shares of Class A common stock issued in the PIPE Investment, (iii) 23,714,946 shares of Class A common stock issued to our directors, officers and affiliates and the directors, officers and affiliates of Legacy Hyperfine, (iv) 614,000 shares of Class A common stock issued in the Private Placement, (v) 300,000 shares issued following the closing of the Business Combination, and (vi) 15,055,288 shares of Class B common stock issued pursuant to the Business Combination Agreement.

10-K filing | 55.3M shares outstanding

8-K filing: HealthCor sold 12,610,000 shares of Class A common stock at $10.00 per share for $126,100,000 in a PIPE Investment and issued 300,000 shares of Class A common stock to a service provider in lieu of $3.0 million of cash compensation. ($126.1M proceeds)

10-Q filing | 5.2M shares outstanding

10-Q filing | 5.2M shares outstanding

8-K filing: HealthCor Catalio Acquisition Corp. entered into a business combination agreement with Hyperfine, Inc. and Liminal Sciences, Inc., and concurrently entered into subscription agreements with PIPE Investors for the purchase of 12,610,000 shares of New Hyperfine Class A common stock at $10.00 per share. ($126.1M proceeds)

10-Q filing | 1.7M shares outstanding

8-K filing: HealthCor Catalio Acquisition Corp. consummated an initial public offering of 20,700,000 Class A ordinary shares at $10.00 per Share and a private placement with HC Sponsor LLC of 614,000 Class A ordinary shares. ($207.0M proceeds)

8-K filing: HealthCor Catalio Acquisition Corp. consummated its IPO of 20,700,000 Class A ordinary shares at $10.00 per share, generating gross proceeds of $207,000,000, and simultaneously completed a private placement of 614,000 Class A ordinary shares to HC Sponsor LLC at $10.00 per share, generating gross proceeds of $6,140,000. ($213.14M proceeds)

S-1/A filing: This S-1/A filing describes an initial public offering of Class A ordinary shares of HealthCor Catalio Acquisition Corp, a blank check company, along with private placements of Class A ordinary shares to the sponsor.

S-1 filing: HealthCor Catalio Acquisition Corp. is a newly organized blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which we refer to as our initial business combination.

S-1/A filing: HealthCor Catalio Acquisition Corp. is a newly organized blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which we refer to as our initial business combination.